SPOTLIGHT INNOVATION LECTURE: TMVr Innovation in the TEER Era: Time to Re-Evaluate Innovation Priorities?
We Recommend
Disclosures
Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below:
- Consultant Fee/Honoraria/Speaker's Bureau - Medtronic; LivaNova; Highlife; Boston Scientific Corporation; Jena Valve; CardioMech; Mitral Technology; Millipede, Cardiovalve, Pie Cardia, Ancora, MTEX
- Paid Proctor - Medtronic
- Equity/Stock(s)/Options - InSeal Medical; Cardiovalve; Claret; Shockwave; Valve Medical; Millipede, Pie-Cardia, Imperative Nedical, MTEx, Ancora